Journal of Drug Targeting

基本信息

期刊简写: J DRUG TARGET
影响因子: 4.3
ISSN: 1061-186X
研究领域: MEDICAL
h-index: 80
自引率: 2.6%
年发文量: 69

SCI收录来源: Science Citation Index Expanded
期刊官网: https://www.tandfonline.com/journals/idrt20
期刊介绍:

Journal of Drug Targeting is a subscription-based, peer-reviewed journal that publishes research on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs. Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules, as well as on the identification of novel drug targets. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, RNA-based therapeutics (e.g. mRNA, microRNAs), gene-editing and gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as small-molecule drugs, aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of therapeutic, diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns. Journal of Drug Targeting also carries papers on the physiological and other biological barriers to delivery and targeting, and means of overcoming the barriers, for example, by penetration enhancers, and covers subjects such as extravasation, diffusion in tumours and target tissues, avoidance of the reticulo-endothelial system, and toxicity testing and licensing of novel delivery systems. The journal’s audience includes, but is not limited to, scientists working in the pharmaceutical and biopharmaceutical sciences, drug delivery and targeting, molecular and biological sciences, pharmacology, toxicology, chemistry, and materials/polymer sciences. Journal of Drug Targeting welcomes for consideration the following types of article: original articles, reviews, article commentaries, book reviews, letters, communications, and method articles. All articles received by the Journal will be subject to single-anonymous peer review.

CiteScore

CiteScore
9.1
SJR
0.849
SNIP
0.706
学科 排名 百分位
Pharmacology, Toxicology and PharmaceuticsPharmaceutical Science
23 / 183 87%

期刊统计

Bimonthly
期/年
13 days avg. from submission to first decision 43 days avg. from submission to first post-review decision 10 days avg. from acceptance to online publication
审稿周期
论文处理费

投稿信息

投稿网址:

https://mc.manuscriptcentral.com/gdrt

相关文献

Dynamic kinetic resolution of β-keto sulfonesvia asymmetric transfer hydrogenation

Zhenhua Ding, Jin Yang, Ting Wang, Zongxuan Shen, Yawen Zhang

2008-12-19 Communication

DOI: 10.1039/B818257D

2-Phenylpyrimidine skeleton-based electron-transport materials for extremely efficient green organic light-emitting devices

Hisahiro Sasabe, Takayuki Chiba, Shi-Jian Su, Yong-Jin Pu, Ken-ichi Nakayama, Junji Kido

2008-10-03 Communication

DOI: 10.1039/B812270A

Reactions over catalysts confined in carbon nanotubes

Xiulian Pan, Xinhe Bao

2008-10-14 Feature Article

DOI: 10.1039/B810994J

Engineered carbohydrate-binding module (CBM) protein-suspended single-walled carbon nanotubes in water

Qi Xu, Qing Song, Xin Ai, Timothy J. McDonald, Hai Long, Shi-You Ding, Michael E. Himmel, Garry Rumbles

2008-11-21 Communication

DOI: 10.1039/B815597F

New 6-oxa-2-silabicyclo[2.2.0]hexanes by photochemical conversion of acyl(allyl)(dimethyl)silanes

Catherine Hammaecher, Charles Portella

2008-09-30 Communication

DOI: 10.1039/B812550C

Back matter

Front/Back Matter

DOI: 10.1039/B818510G

Morphological changes in the self-assembly of a radial oligo-phenylene ethynylene amphiphilic system

Gustavo Fernández, Fátima García, Luis Sánchez

2008-11-12 Communication

DOI: 10.1039/B818378C

A template-free nano-wrapping technique for the fabrication of copper hollow nanospheres smaller than 20 nm

Frank Leung-Yuk Lam, Tommy Chi-Yan Martin, Xijun Hu

2008-11-04 Communication

DOI: 10.1039/B812651H

您可能还喜欢

化合物问答

4-[4-三氟甲基苯基]恶唑(CAS号:1126636-40-5)通常如何合成?

4-[4-三氟甲基苯基]恶唑通常通过将4-三氟甲基苯酚与异硫氰酸苯酯在有机溶剂中进行酯化反应合成。该反应可在无水条件下,使用适当的催化剂,如四丁基氢氧化铵,以提...

1126636-40-54-(4-(Trifluoromethy...
化合物问答

氢溴酸西酞普兰(CAS号:59729-32-7)的主要用途是什么?

氢溴酸西酞普兰主要用于治疗抑郁症,通过调节大脑中的神经递质平衡来改善情绪。

59729-32-71-[3-(Dimethylamino)...
化合物问答

RockPhos Pd G3(CAS号:2009020-38-4)通常如何合成?

RockPhos Pd G3 通常通过钯催化偶联反应合成,使用配体 (2'-Amino-2-biphenylyl)(methanesulfonato-kappa...

2009020-38-4(2'-Amino-2-biphenyl...
化合物问答

1-哌啶甲酰胺(CAS号:2158-03-4)的市场或研究趋势如何?

1-哌啶甲酰胺作为有机合成中的重要中间体,其市场需求主要受医药、农药、染料等行业推动。近年来,随着新药开发和绿色化学的发展,该化合物的研究趋势集中在开发更高效、...

2158-03-41-Piperidinecarboxam...
化合物问答

2-(二苯基膦基)乙胺(CAS号:4848-43-5)适用哪些法规指南?

2-(二苯基膦基)乙胺适用于多种法规指南,包括但不限于《全球化学品统一分类和标签制度》(GHS),欧盟《化学品注册、评估、授权和限制》法规(REACH),以及美...

4848-43-52-(Diphenylphosphino...
化合物问答

如何储存间苯二甲酸二烯丙酯(CAS号:1087-21-4)?

间苯二甲酸二烯丙酯应储存在阴凉、干燥、通风良好的地方,远离火源和热源。储存容器应密封,避免光照和高温。储存温度应控制在25℃以下,相对湿度应低于80%。避免与其...

1087-21-4Diallyl isophthalate
化合物问答

什么是间甲苯异硫代异氰酸酯(CAS号:621-30-7)?

间甲苯异硫代异氰酸酯是一种有机化合物,分子式为C7H7NO2S,具有刺激性气味。它是一种重要的有机合成中间体,在合成其他化合物时广泛应用。

621-30-71-Isothiocyanato-3-m...
化合物问答

在合成中是否有N-Boc-D-苯丙氨醇(CAS号:106454-69-7)的替代品?

在合成中,可以考虑使用N-Cbz-D-苯丙氨醇或N-Fmoc-D-苯丙氨醇作为替代品。这些化合物同样具有保护氨基的功能,且在合成过程中表现出良好的反应性能。

106454-69-72-Methyl-2-propanyl ...
化合物问答

3-羟甲基-2-氧异丙基吡啶(CAS号:954240-50-7)的主要用途是什么?

3-羟甲基-2-氧异丙基吡啶主要用于有机合成领域,可以作为合成其他药物、农药或精细化学品的中间体。此外,它还可能在实验室研究中作为特定反应的前体或溶剂。

954240-50-7(2-Isopropoxy-3-pyri...
化合物问答

6-氨基-9-甲基嘌呤(CAS号:700-00-5)应用于哪些行业?

6-氨基-9-甲基嘌呤目前主要应用于医药行业,作为某些药物的中间体。此外,它还可能用于聚合物、传感器和半导体的某些领域,作为功能性单体或掺杂剂。

700-00-59-Methyl-9H-purin-6-...
免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。